Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
10 hedge funds and large institutions have $845K invested in Genetic Technologies Ltd. in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 5 closing their positions.
9% less funds holding
Funds holding: 11 → 10 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
27% less capital invested
Capital invested by funds: $1.16M → $845K (-$318K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$35.6K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$30K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$18.5K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.62K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$193K |
| 2 |
Jane Street
New York
|
-$52K |
| 3 |
Morgan Stanley
New York
|
-$24.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$10K |
| 5 |
Renaissance Technologies
New York
|
-$6.75K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $726K | -$6.75K | -155 | -1% |
|
|
2
Citadel Advisors
Miami,
Florida
| $38K | +$35.6K | +818 | New |
|
|
VKH
3
Virtu KCG Holdings
New York
| $32K | +$30K | +689 | New |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $20K | +$18.5K | +425 | New |
|
|
5
Morgan Stanley
New York
| $15K | -$24.4K | -561 | -63% |
|
|
6
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $7K | +$6.62K | +152 | New |
|
|
LTFS
7
Ladenburg Thalmann Financial Services
Miami,
Florida
| $6K | – | – | – |
|
8
Creative Planning
Overland Park,
Kansas
| $1K | – | – | – |
|
|
OAM
9
Oxford Asset Management
Oxford,
United Kingdom
| – | -$193K | -3,560 | Closed |
|
|
10
Jane Street
New York
| – | -$52K | -972 | Closed |
|
|
11
UBS Group
Zurich,
Switzerland
| – | -$10K | -194 | Closed |
|
|
AIA
12
Allegis Investment Advisors
Idaho Falls,
Idaho
| – | -$1K | -28 | Closed |
|
13
Simplex Trading
Chicago,
Illinois
| – | -$740 | -17 | -94% |
|
|
TRCT
14
Tower Research Capital (TRC)
New York
| – | -$1K | -17 | Closed |
|
15
Citigroup
New York
| – | -$305 | -7 | -88% |
|
GENE Hedge Fund Activity: Q1 2016 in Review
10 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q1 2016, worth a combined $845K — down 27% from $1.16M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of GENE and 4 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 0 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $35.6K. The largest seller was Oxford Asset Management, exiting entirely with an estimated $193K sold.
- 10 institutional investors held Genetic Technologies Ltd. (GENE) as of Q1 2016, down from 11 in Q4 2015.
- Funds reported $845K of Genetic Technologies Ltd. stock for Q1 2016, down 27% quarter-over-quarter.
- 4 funds opened new Genetic Technologies Ltd. positions in Q1 2016 and 5 closed out, a net change of -1 holder.
- The largest Genetic Technologies Ltd. buyer in Q1 2016 was Citadel Advisors, an estimated $35.6K added.
- The largest Genetic Technologies Ltd. seller in Q1 2016 was Oxford Asset Management, an estimated $193K sold.
Based on aggregated 13F filings for Q1 2016.